These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

159 related items for PubMed ID: 31416117

  • 1. Synthesis and Antiproliferative Activity of Novel A-Ring Cleaved Glycyrrhetinic Acid Derivatives.
    Alho DPS, Salvador JAR, Cascante M, Marin S.
    Molecules; 2019 Aug 14; 24(16):. PubMed ID: 31416117
    [Abstract] [Full Text] [Related]

  • 2. Synthesis and Antiproliferative Activity of Novel Heterocyclic Glycyrrhetinic Acid Derivatives.
    Alho DPS, Salvador JAR, Cascante M, Marin S.
    Molecules; 2019 Feb 20; 24(4):. PubMed ID: 30791593
    [Abstract] [Full Text] [Related]

  • 3. Synthesis and biological activity of some antitumor active derivatives from glycyrrhetinic acid.
    Csuk R, Schwarz S, Kluge R, Ströhl D.
    Eur J Med Chem; 2010 Dec 20; 45(12):5718-23. PubMed ID: 20884085
    [Abstract] [Full Text] [Related]

  • 4. Discovery of 18β-glycyrrhetinic acid conjugated aminobenzothiazole derivatives as Hsp90-Cdc37 interaction disruptors that inhibit cell migration and reverse drug resistance.
    Jin L, Huang R, Huang X, Zhang B, Ji M, Wang H.
    Bioorg Med Chem; 2018 May 01; 26(8):1759-1775. PubMed ID: 29486954
    [Abstract] [Full Text] [Related]

  • 5. Synthesis of novel heterocyclic ring-fused 18β-glycyrrhetinic acid derivatives with antitumor and antimetastatic activity.
    Gao C, Dai FJ, Cui HW, Peng SH, He Y, Wang X, Yi ZF, Qiu WW.
    Chem Biol Drug Des; 2014 Aug 01; 84(2):223-33. PubMed ID: 24612785
    [Abstract] [Full Text] [Related]

  • 6. Synthesis and biological activity of glycyrrhetinic acid derivatives as antitumor agents.
    Zhou F, Wu GR, Cai DS, Xu B, Yan MM, Ma T, Guo WB, Zhang WX, Huang XM, Jia XH, Yang YQ, Gao F, Wang PL, Lei HM.
    Eur J Med Chem; 2019 Sep 15; 178():623-635. PubMed ID: 31226654
    [Abstract] [Full Text] [Related]

  • 7. Synthesis and pro-apoptotic activity of novel glycyrrhetinic acid derivatives.
    Logashenko EB, Salomatina OV, Markov AV, Korchagina DV, Salakhutdinov NF, Tolstikov GA, Vlassov VV, Zenkova MA.
    Chembiochem; 2011 Mar 21; 12(5):784-94. PubMed ID: 21328513
    [Abstract] [Full Text] [Related]

  • 8. Synthesis and antitumor activity of ring A modified glycyrrhetinic acid derivatives.
    Csuk R, Schwarz S, Siewert B, Kluge R, Ströhl D.
    Eur J Med Chem; 2011 Nov 21; 46(11):5356-69. PubMed ID: 21959232
    [Abstract] [Full Text] [Related]

  • 9. Synthesis and biological evaluation of novel spin labeled 18β-glycyrrhetinic acid derivatives.
    Liu Y, Qian K, Wang CY, Chen CH, Yang X, Lee KH.
    Bioorg Med Chem Lett; 2012 Dec 15; 22(24):7530-3. PubMed ID: 23122524
    [Abstract] [Full Text] [Related]

  • 10. Discovery of novel 4(1H)-quinolone derivatives as potential antiproliferative and apoptosis inducing agents.
    Zhou P, Huang L, Zhou J, Jiang B, Zhao Y, Deng X, Zhao Q, Li F.
    Bioorg Med Chem Lett; 2017 Sep 01; 27(17):4185-4189. PubMed ID: 28757067
    [Abstract] [Full Text] [Related]

  • 11. Synthesis and evaluation of triazole linked glycosylated 18β-glycyrrhetinic acid derivatives as anticancer agents.
    Parida PK, Sau A, Ghosh T, Jana K, Biswas K, Raha S, Misra AK.
    Bioorg Med Chem Lett; 2014 Aug 15; 24(16):3865-8. PubMed ID: 25027936
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Mitochondria-targeted triphenylphosphonium conjugated glycyrrhetinic acid derivatives as potent anticancer drugs.
    Jin L, Dai L, Ji M, Wang H.
    Bioorg Chem; 2019 Apr 15; 85():179-190. PubMed ID: 30622010
    [Abstract] [Full Text] [Related]

  • 14. QSAR and docking based semi-synthesis and in vitro evaluation of 18 β-glycyrrhetinic acid derivatives against human lung cancer cell line A-549.
    Yadav DK, Kalani K, Khan F, Srivastava SK.
    Med Chem; 2013 Dec 15; 9(8):1073-84. PubMed ID: 23675978
    [Abstract] [Full Text] [Related]

  • 15. An Overview of Structurally Modified Glycyrrhetinic Acid Derivatives as Antitumor Agents.
    Xu B, Wu GR, Zhang XY, Yan MM, Zhao R, Xue NN, Fang K, Wang H, Chen M, Guo WB, Wang PL, Lei HM.
    Molecules; 2017 Jun 02; 22(6):. PubMed ID: 28574470
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. 18β-Glycyrrhetinic acid derivatives induced mitochondrial-mediated apoptosis through reactive oxygen species-mediated p53 activation in NTUB1 cells.
    Lin KW, Huang AM, Hour TC, Yang SC, Pu YS, Lin CN.
    Bioorg Med Chem; 2011 Jul 15; 19(14):4274-85. PubMed ID: 21696969
    [Abstract] [Full Text] [Related]

  • 18. Synthesis and Biological Evaluation of Glycyrrhetic Acid Derivatives as Potential VEGFR2 Inhibitors.
    Yan TL, Bai LF, Zhu HL, Zhang WM, Lv PC.
    ChemMedChem; 2017 Jul 06; 12(13):1087-1096. PubMed ID: 28599090
    [Abstract] [Full Text] [Related]

  • 19. Does one keto group matter? Structure-activity relationships of glycyrrhetinic acid derivatives modified at position C-11.
    Csuk R, Schwarz S, Kluge R, Ströhl D.
    Arch Pharm (Weinheim); 2012 Jan 06; 345(1):28-32. PubMed ID: 22076975
    [Abstract] [Full Text] [Related]

  • 20. The synthesis of 18beta-glycyrrhetinic acid derivatives which have increased antiproliferative and apoptotic effects in leukemia cells.
    Liu D, Song D, Guo G, Wang R, Lv J, Jing Y, Zhao L.
    Bioorg Med Chem; 2007 Aug 15; 15(16):5432-9. PubMed ID: 17566745
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.